Sign Up to like & get
recommendations!
1
Published in 2023 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30572
Abstract: Identification and management of patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI) have been of great interest in the last years, due to the higher incidence of adverse events in this population.…
read more here.
Keywords:
bleeding risk;
high bleeding;
hbr patients;
non hbr ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cardiovascular Drugs and Therapy"
DOI: 10.1007/s10557-018-6823-9
Abstract: PurposePatients with high bleeding risk (HBR) who undergo percutaneous coronary intervention also have an increased risk of ischemic events and represent an overall high-risk population. The coating of durable polymer drug-eluting stents (DP-DES) may induce…
read more here.
Keywords:
risk;
strut;
strut des;
thin strut ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2018.03.116
Abstract: BACKGROUND The prospective observational CHANGE DAPT study compared clopidogrel versus ticagrelor-based dual antiplatelet (DAPT) regimens in consecutive patients with acute coronary syndrome (ACS), treated with percutaneous coronary intervention (PCI) with contemporary drug-eluting stents (DES). During…
read more here.
Keywords:
risk;
ticagrelor;
patients acute;
hbr ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.2511
Abstract: The Academic Research Consortium (ARC) has recently published a consensus-based definition to identify patients at high bleeding risk (HBR), reflected by a BARC 3 or 5 bleeding rate of ≥4% at 1 year after percutaneous…
read more here.
Keywords:
hbr;
non hbr;
one minor;
hbr patients ... See more keywords